Christina Takke

Christina Takke is the managing partner at V-Bio Ventures. Christina has extensive experience in the biotech industry, having served on the boards of several companies, including Precirix, OCTIMET Oncology NV, OXULAR LIMITED, Confo Therapeutics, and Syndesi Therapeutics. Christina also spent a year as an independent advisor, providing strategic and development advice to various biotech companies. Christina has a proven track record of success, having helped argenx achieve an IPO on Euronext Brussels.

Christina Takke has a PhD in Developmental Biology from the University of Cologne. Christina also has a Bachelor's degree in Developmental Biology from the Institut National de la Recherche Agronomique (INRA) and a Diplom in Biology from the Technische Universität Darmstadt.

Aurelie Nowack - Principal, Katja Rosenkranz - Partner, and Ward Capoen - Partner report to Christina Takke.